Gabriel Leung Insider Profile

4 Followers
Gabriel Leung, Director at Albany Molecular Research, holds 31.32K shares in Albany Molecular Research (Ticker: AMRI), holds 0.00 shares in Pernix Therapeutics (Ticker: PTXTQ), holds 83.19K shares in NovoCure (Ticker: NVCR).
tipranks
Gabriel Leung

Gabriel Leung
Albany Molecular Research (AMRI)
Director

Ranked #92,843 out of 99,218 Corporate Insiders

Profitable Transactions

20%
2 out of 10 Profitable Transactions

Average Return

-34.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
85.93%
14.07%
A breakdown of Gabriel Leung's holdings

Insider Roles

NovoCure
(NVCR)
Director
Delcath Systems
(DCTH)
Director
Roles that Gabriel Leung holds in companies

Most Profitable Insider Trade

Stock:
NovoCure
(NVCR)
Rating:Informative Sell
Date:Jun 06, 2024 - Today
Return:+26.90%
The most profitable trade made by Gabriel Leung

Gabriel Leung's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AMRI
Albany Molecular Research
Mar 04, 2015
Uninformative Buy
44.99K
$680.81K
PTXTQ
Pernix Therapeutics
$0.00
NovoCure
Jun 06, 2024
Director
Uninformative Buy
$1.45M
Delcath Systems
Jul 09, 2014
Director
Uninformative Buy
$237.62K
List of latest transactions for each holding click on a transaction to see Gabriel Leung's performance on stock

Gabriel Leung insider profile FAQ

What is the percentage of profitable transactions made by Gabriel Leung?
The percentage of profitable transactions made by Gabriel Leung is 20%.
    What is the average return per transaction made by Gabriel Leung?
    The average return per transaction made by Gabriel Leung is -34.30%.
      What stocks does Gabriel Leung hold?
      Gabriel Leung holds: AMRI, PTXTQ, NVCR, DCTH stocks.
        What was Gabriel Leung’s latest transaction?
        Gabriel Leung latest transaction was an Uninformative Buy of $44.99K.
          What was Gabriel Leung's most profitable transaction?
          Gabriel Leung’s most profitable transaction was an Informative Sell of NVCR stock on June 6, 2024. The return on the trade was 26.90%.
            What is Gabriel Leung's role in Albany Molecular Research?
            Gabriel Leung's role in Albany Molecular Research is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.